Università degli studi di Roma Tor VergataRome, Italy
NA
(1498877) XPO1 mutations identify early stage CLL characterized by shorter time to first treatment and enhanced BCR signaling
Friday, October 6, 202311:35 AM – 11:40 AM EDT
(1552495) Impact of COVID-19 in patients with Chronic Lymphocytic Leukemia treated with venetoclax: a possible role of the association to anti-CD20 antibody? A multicentre SEIFEM study.
Friday, October 6, 20231:50 PM – 1:55 PM EDT
(1553031) Constituitive VLA-4 activation is linked to BCR autonomous signaling in circulating CLL cells and promotes pro-survival signals through soluble blood-borne VCAM-1 binding
Saturday, October 7, 20233:05 PM – 3:15 PM EDT
